Cosmetics is a prominent open-access journal published by MDPI in Switzerland, dedicated to advancing research in the fields of dermatology, pharmaceutical science, and chemical engineering, among others. Launched in 2014, this interdisciplinary journal seeks to provide a platform for the dissemination of innovative studies surrounding topical formulations, cosmetic development, and skin health, contributing to a deeper understanding of aging processes and their implications in cosmetic science. With an impressive array of quartile rankings, including Q2 placements in key categories such as Chemical Engineering and Dermatology, as well as a strong Scopus ranking showing its relevance and impact within the community, Cosmetics serves as a vital resource for researchers, professionals, and students alike. Access to its rich content is readily available through its open-access model, ensuring that breakthroughs in cosmetic science are shared widely to promote knowledge and inspire further innovation within this dynamic field.

The Journal of Aerosol Medicine and Pulmonary Drug Delivery, published by MARY ANN LIEBERT, INC, is a distinguished journal dedicated to advancing the field of aerosol medicine and pharmacology. With an ISSN of 1941-2711 and E-ISSN 1941-2703, the journal has established itself as an essential resource for researchers and professionals specializing in pharmaceutical sciences and pulmonary medicine. Ranking in the Q2 category across multiple disciplines, including Pharmaceutical Science and Pulmonary and Respiratory Medicine, it holds notable Scopus rankings, with a percentile of 78th in Pulmonary and Respiratory Medicine. The journal offers open access options, ensuring that cutting-edge research is readily available to a global audience. With converged years from 2008 to 2024, the Journal of Aerosol Medicine and Pulmonary Drug Delivery continues to serve as a vital platform for disseminating innovative research findings, clinical practice insights, and technological advancements in drug delivery systems, thereby significantly impacting therapeutic strategies for respiratory diseases.

The British Journal of Dermatology, published by Oxford University Press, stands as a premier platform for advancing the field of dermatological research and clinical practice since its inception in 1892. With a strong commitment to disseminating high-quality research, this esteemed journal is currently ranked in the Q1 category for both Dermatology and Miscellaneous Medicine in 2023, reflecting its influential position in the academic landscape. As the leading journal in its field, it enjoys a robust Scopus ranking of #1 out of 142 in dermatology, placing it in the 99th percentile globally. The journal covers a wide scope of subjects pertinent to dermatology, including clinical trials, treatment innovations, and epidemiological studies, making it an essential resource for researchers, healthcare professionals, and students alike. Although it is not an open-access publication, it ensures a broad reach through institutional subscriptions, fostering knowledge exchange across the global dermatological community. Based in the heart of the United Kingdom, the British Journal of Dermatology continues to play a crucial role in shaping the future of skin health and disease management.

SKIN RESEARCH AND TECHNOLOGY, a distinguished publication by Wiley, stands at the forefront of dermatological science, emphasizing innovative research and technological advances in skin health. With an ISSN of 0909-752X and an E-ISSN of 1600-0846, this journal serves as a vital platform for researchers and professionals to present their findings and engage in discussions surrounding skin biology, clinical practices, and therapeutic technologies. As evidenced by its respectable Q2 ranking in the dermatology category for 2023 and a Q3 status in miscellaneous medicine, the journal attracts a broad readership and contributes significantly to the field. Housed in the United Kingdom with publications spanning from 1995 to 2024, SKIN RESEARCH AND TECHNOLOGY continues to foster innovation and knowledge dissemination in skin-related research. While its Access options are not open, the impact of the journal remains prominent, appealing to academic professionals and students eager to explore emerging trends and advancements in dermatological studies.

DERMATOLOGIC CLINICS is a leading journal in the field of dermatology, published by W B SAUNDERS CO-ELSEVIER INC. Since its inception in 1983, the journal has consistently provided a platform for the dissemination of high-quality research and clinical insights, earning its place in the prestigious Q1 quartile for dermatology in 2023. With a Scopus ranking of #34 out of 142 in its category and a commendable 76th percentile, DERMATOLOGIC CLINICS remains essential reading for clinicians, researchers, and students alike. The journal features comprehensive reviews and original articles that address the latest advancements and challenges in dermatologic diagnostics and treatments. Though it does not offer Open Access, it is widely accessible ensuring a broad readership. With a commitment to advancing the understanding of skin disorders, DERMATOLOGIC CLINICS continues to uphold its legacy of excellence in dermatological scholarship.

Journal of Cosmetic Science, published by the Society of Cosmetic Chemists, serves as a pivotal resource for researchers and professionals in the fields of cosmetic science, dermatology, and chemistry. With a commitment to advancing the understanding of cosmetic formulations and skin biology, this journal has been providing a platform for critical scholarly exchange since its inception in 1996. Although currently categorized in Q4 quartiles across essential domains like Chemistry and Dermatology, the journal distinguishes itself with a focus on innovative research that drives the cosmetic industry forward. Researchers can access the journal through conventional routes as well as explore changes to its open-access policies, ensuring a broad dissemination of knowledge. As the cosmetic landscape evolves, this journal plays an important role in bridging the gap between scientific research and practical application, making it indispensable for students and professionals alike who are eager to stay at the forefront of cosmetic science.

PHARMACEUTICAL RESEARCH, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal in the ever-evolving field of pharmaceutical sciences. With an ISSN of 0724-8741 and an E-ISSN of 1573-904X, this journal has established itself as a critical hub for disseminating innovative research from 1984 to 2024. The journal holds impressive rankings in prominent categories, including Q2 in Biotechnology and Q2 in Pharmaceutical Science, reflecting its robust impact on the global scientific community. The journal aims to provide researchers, professionals, and students with high-quality articles that contribute significantly to the advancement of drug development and medicinal applications. Although it does not currently offer Open Access options, its rigorous peer-review process ensures that only the highest caliber research is published, making it a valuable resource for those seeking to stay at the forefront of pharmaceutical innovation.

Journal of Pharmacy & Pharmacognosy Research, published by JOURNAL PHARMACY & PHARMACOGNOSY RESEARCH-JPPRES, is a prominent open-access journal established in 2013, headquartered in Antofagasta, Chile. With a focus on the fields of Complementary and Alternative Medicine, Drug Discovery, Pharmaceutical Science, Pharmacology, and Pharmacy, this journal is recognized for its commitment to advancing research and disseminating knowledge within these important areas. With a current impact factor that reflects its academic rigor and relevance, the journal has achieved substantial recognition, evident by its Q2 and Q3 quartile rankings in multiple categories, indicating its growing influence on the scientific community. The Scopus rankings further highlight its standing in pharmacy and pharmacological disciplines, providing a valuable platform for researchers, professionals, and students to share their findings and insights. With its open access model, the journal ensures that high-quality research is available to a global audience, paving the way for collaborative advancements in pharmaceutical sciences.

Pakistan Journal of Pharmaceutical Sciences, published by the University of Karachi, serves as a vital platform for advancing research in the field of pharmaceutical sciences. With a strong commitment to disseminating innovative findings and critical studies since its inception in 1995, the journal focuses on a wide array of topics including pharmacology, toxicology, and pharmaceutics. With an ISSN of 1011-601X, it holds a reputable position within the academic community, reflecting its Q3 category ranking in Pharmaceutical Science as of 2023. While the journal is currently not designated as Open Access, it remains accessible through institutional subscriptions, ensuring that both emerging and established researchers can contribute to and benefit from its scholarly content. This publication not only promotes scientific dialogue but also aims to bridge the gap between academia and industry, appealing to a diverse audience of researchers, professionals, and students seeking to stay informed about the latest advancements and trends in pharmaceutical research.

The European Journal of Pharmaceutical Sciences is a prestigious academic journal dedicated to advancing the field of pharmaceutical science. Published by Elsevier, the journal boasts an impressive impact factor and is categorized in the Q1 quartile for pharmaceutical science as of 2023, signifying its influence and reputation within the academic community. With a Scopus ranking of #20 out of 183 in the fields of pharmacology, toxicology, and pharmaceutics, the journal provides a vital platform for researchers and practitioners to disseminate innovative studies and groundbreaking research that push the boundaries of drug development and delivery. Based in the Netherlands and operating since 1993, the journal seeks to cover a broad scope of topics related to pharmaceutical sciences, encouraging rigorous evaluations and discussions that enhance the understanding and application of this critical field. The absence of open access underscores the commitment to maintaining high scholarly standards, while still offering avenues for libraries and institutions to provide access to cutting-edge research. As the journal converges towards its 2024 milestones, it continuously aims to foster a vibrant exchange of knowledge among its diverse readership, comprising committed researchers, professionals, and students.